APPLICATION
ANDA213424
TYPE
ANDA
ORIGINAL APPROVAL
2021-03-19
LATEST ACTION
2021-03-19
ROUTE
ENDOTRACHEAL, INTRAMEDULLARY, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ATROPINE SULFATEPrescription
ATROPINE SULFATE 8MG/20ML (0.4MG/ML) · SOLUTION · INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.